According to a new report published by UnivDatos, the Herpes Zoster Treatment Market is expected to grow at a CAGR of around 4% from 2022-2028. The analysis has been segmented into Treatment Type (Antiviral Medications, Anti-Inflammatory Medications, and Others); Route of Administration (Oral, Topical, and Others); Distribution Channel (Retail Pharmacies, Online Pharmacies, Hospital Pharmacies, and Others); Region/Country.

The herpes zoster treatment market report has been aggregated by collecting informative data on various dynamics such as market drivers, restraints, and opportunities. This innovative report makes use of several analyses to get a closer outlook on the herpes zoster treatment market. The herpes zoster treatment market report offers a detailed analysis of the latest industry developments and trending factors in the market that are influencing the market growth. Furthermore, this statistical market research repository examines and estimates the herpes zoster treatment market at the global and regional levels.

Access sample report (including graphs, charts, and figures): https://univdatos.com/reports/herpes-zoster-treatment-market?popup=report-enquiry

Market Overview

Shingles (herpes zoster) is a viral infection that causes an outbreak of a painful rash or blisters on the skin. It's caused by the varicella-zoster virus, which is the same virus that causes chickenpox. It is a common disease in immunocompromised individuals and in the old-aged population. In this disease, the chickenpox virus becomes dormant and re-activates when immunity compromises. The rising geriatric population is one of the important factors that is responsible for the increasing cases of shingles. For instance, as per the WHO, Between 2015 and 2050, the proportion of the world's population over 60 years will nearly double from 12% to 22%.

COVID-19 Impact

COVID-19 has a staggering effect on the global market. The market for zoster treatment also faced the negative impact of the pandemic. This may be ascribed to disruptive supply chains, lockdowns, and a fall in the number of patient visits in the hospitals.

The global herpes zoster treatment market report is studied thoroughly with several aspects that would help stakeholders in making their decisions more curated.

·       Based on the treatment type, the market has been categorized into antiviral medications, anti-inflammatory medications, and others. Among them, the antiviral category is expected to witness lucrative growth during the forecast period. Active participation of the government in the vaccination programs and the rising demand for antiviral drugs are attributed to the growth of the segment in the herpes zoster treatment market. For instance, in 2013, the Shingles National Immunisation Programme was introduced by the U.K. Department of Health. In September 2020, all eligible 70 to 79-year-olds were included in the program.

·       Based on the route of administration, the market has been categorized into oral, topical, and others. Among them, the oral segment is expected to have significant growth in the market. The rising demand for an effective and easier route of administration is catalyzing the market growth of oral drugs. Furthermore, increasing the adoption of antiviral drugs is also an important factor that affects the market for oral drugs.

·       Based on the distribution channel, the market is segmented into retail pharmacies, online pharmacies, hospital pharmacies, and others. Hospital pharmacies are expected to witness lucrative growth during the forecast period. This is mainly due to the rising number of hospitalization cases and the increasing number of old-aged patients affected by the disease. For instance, the Canadian Institute of Health Information, the hospitalization rate was 6,687 per 100,000 in 2020–2021.

Have a Look at the Chapters

Herpes Zoster Treatment Market Geographical Segmentation Includes:

·       North America (United States, Canada, and Rest of North America)

·       Europe (Germany, United Kingdom, Spain, Italy, France, and the Rest of Europe)

·       Asia-Pacific (China, Japan, India, and the Rest of Asia-Pacific)

·       Rest of the World

North America constitutes a significant herpes zoster treatment market due to the increasing R&D activities for developing a better and rising geriatric population in the region. Furthermore, the rise the public awareness about the severity of the disease is also responsible for the market growth of the treatment in the region. Additionally, the presence of developed nations such as the U.S in the region and their higher healthcare expenditure and better infrastructure is also responsible for the lucrative market share of the region in the shingles treatment market. For instance, U.S. health care spending grew 9.7 percent in 2020, reaching USD 4.1 trillion or USD 12,530 per person. As a share of the nation's Gross Domestic Product, health spending accounted for 19.7%.

Click here to view the Report Description & TOC: https://univdatos.com/reports/herpes-zoster-treatment-market

The major players targeting the market include

·       Abbott Laboratory

·       Bausch Health

·       Cipla Inc.

·       Camber Pharmaceuticals.

·       GlaxoSmithKline plc

·       Merck

·       Novartis AG

·       Pfizer Inc.

·       Eli Lilly and Co.

·       Teva Pharmaceutical Industries Ltd.

Competitive Landscape

The degree of competition among prominent global companies has been elaborated by analyzing several leading key players operating worldwide. The specialist team of research analysts sheds light on various traits such as global market competition, market share, most recent industry advancements, innovative product launches, partnerships, mergers, or acquisitions by leading companies in the herpes zoster treatment market. The major players have been analyzed by using research methodologies for getting insight views on global competition.

Key questions resolved through this analytical market research report include:

• What are the latest trends, new patterns, and technological advancements in the herpes zoster treatment market?

• Which factors are influencing the herpes zoster treatment market over the forecast period?

• What are the global challenges, threats, and risks in the herpes zoster treatment market?

• Which factors are propelling and restraining the herpes zoster treatment market?

• What are the demanding global regions of the herpes zoster treatment market?

• What will be the global market size in the upcoming years?

• What are the crucial market acquisition strategies and policies applied by global companies?

We understand the requirement of different businesses, regions, and countries, we offer customized reports as per your requirements of business nature and geography. Please let us know If you have any custom needs.

Browse Other Related Research Reports from UnivDatos Market Insights

·       Plasma Fractionation Market

·       Uveitis Treatment Market

·       Chronic Pain Treatment Market

·       Pain Management Devices Market

·       Urethral Stricture Treatment Devices Market

About UnivDatos

UnivDatos is a passionate market research firm and a subsidiary of Universal Data Solutions. We believe in delivering insights through Market Intelligence Reports, Customized Business Research, and Primary Research. Our research studies are spread across topics across the world, we cover markets in over 100 countries using smart research techniques and agile methodologies. We offer in-depth studies, detailed analysis, and customized reports that help shape winning business strategies for our clients.

Contact Us:

UnivDatos

Contact Number - +1 978 733 0253

Email - contact@univdatos.com 

Website - www.univdatos.com

Linkedin- https://www.linkedin.com/company/univ-datos-market-insight/mycompany/